Twenty‐eight years of intestinal transplantation in Paris: experience of the oldest European center. (February 2017)

• Record Type: Journal Article
• Authors: Lacaille, Florence; Irtan, Sabine; Dupic, Laurent; Talbotec, Cécile; Lesage, Fabrice; Colomb, Virinie; Salvi, Nadège; Moulin, Florence; Sauvat, Frédérique; Aigrain, Yves; Revillon, Yann; Goulet, Olivier; Chardot, Christophe
• Is Part Of: Transplant international. Volume 30:Number 2(2017)
• Page Start: 178
• Page End: 186
• Publication Date: 2017-02
• Subjects: graft loss -- intestinal transplantation -- multivisceral transplantation -- survival; Transplantation of organs, tissues, etc -- Periodicals; 617.95405
• DOI: 10.1111/tri.12894
• Languages: English
• ISSNs: 0934-0874

Abstract

Summary: Our aim was to describe our achievements in pediatric intestinal transplantation (ITx) and define areas for improvement. After a period (1987–1990) of nine isolated small bowel transplants (SBTx) where only one patient survived with her graft, 110 ITx were performed on 101 children from 1994 to 2014: 60 SBTx, 45 liver–small bowel, four multivisceral (three with kidneys), and one modified multivisceral. Indications were short bowel syndrome (36), motility disorders (30), congenital enteropathies (34), and others (1). Induction treatment was introduced in 2000. Patient/graft survival with a liver‐containing graft or SBTx was, respectively, 60/41% and 46/11% at 18 years. Recently, graft survival at 5/10 years was 44% and 31% for liver‐containing graft and 57% and 44% for SBTx. Late graft loss occurred in 13 patients, and 7 of 10 retransplanted patients died. The main causes of death and graft loss were sepsis and rejection. Among the 55 currently living patients, 21 had a liver‐containing graft, 19 a SBTx (17 after induction), and 15 were on parenteral nutrition. ITx remains a difficult procedure, and retransplantation even more so. Over the long term, graft loss was due to rejection, over‐immunosuppression was not a significant problem. Multicenter studies on immunosuppression and microbiota are urgently needed.